# OnCo record aurelien-marabelle (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/aurelien-marabelle/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "aurelien-marabelle" ;
  schema:name "Aurélien Marabelle"@en ;
  schema:description "Aurélien Marabelle is the immunotherapy investigator behind the tumour-agnostic pembrolizumab data in MSI-high cancers."@en ;
  schema:url <https://onco.cc/people/aurelien-marabelle/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Marabelle%20A%5BAuthor%5D%20pembrolizumab> ;
  schema:jobTitle "Clinical Director, Cancer Immunotherapy Program (DITEP), Gustave Roussy" ;
  schema:sameAs <https://orcid.org/0000-0002-5816-3019> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/gustave-roussy/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/terms/tmb/> ;
  schema:affiliation <https://onco.cc/institutions/gustave-roussy/> .